Beneficial effects of oral Premarin [conjugated estrogens] estrogen replacement therapy assessed by human genome array
Phase of Trial: Phase I
Latest Information Update: 14 Jul 2009
At a glance
- Drugs Conjugated estrogens (Primary)
- Indications Dyspareunia; Menopausal syndrome; Postmenopausal osteoporosis
- Focus Pharmacodynamics
- 14 Jul 2009 Actual end date (Feb 2007) added as reported by ClinicalTrials.gov.
- 14 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 May 2007 Status changed from recruiting to in progress.